Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico
Viruses · 2024
DOI: 10.3390/v16060887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von José L Castrillo-Diez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leire Genomic Laboratories, León 37000, Mexico. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We have been encouraging practicing gynecologists to adopt molecular diagnostics tests, PCR, and cancer biomarkers, as alternatives enabled by these platforms, to traditional Papanicolaou and colposcopy tests, respectively. An aliquot of liquid-based cytology was used for the molecular test [high-risk HPV types, (HR HPV)], another for the PAP test, and one more for p16/Ki67 dual-stain cytology. A total of 4499 laboratory samples were evaluated, and we found that 25.1% of low-grade samples and 47.9% of high-grade samples after PAP testing had a negative HR HPV-PCR result. In those cases, reported as Pap-negative, 22.1% had a positive HR HPV-PCR result. Dual staining with p16/Ki67 biomarkers in samples was positive for HR HPV, and 31.7% were also positive for these markers. Out of the PCR results that were positive for any of these HR HPV subtypes, n 68.3%, we did not find evidence for the presence of cancerous cells, highlighting the importance of performing dual staining with p16/Ki67 after PCR to avoid unnecessary colposcopies. The encountered challenges are a deep-rooted social reluctance in Mexico to abandon traditional Pap smears and the opinion of many specialists. Therefore, we still believe that colposcopy continues to be a preferred procedure over the dual-staining protocol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leire Genomic Laboratories, León 37000, Mexico.
- Columbia Biotec, Columbia Laboratories, Tlalpan 14090, Mexico.
- Columbia Laboratories, Basic Scientific Research Division, Mexico City 04000, Mexico.
- Innbiogem SC/Vitagenesis SA at National Laboratory for Services of Research, Development, and Innovation for the Pharma and Biotech Industries (LANSEIDI) of CONACyT Vitaxentrum Group, Monterrey 64630, Mexico.
- Facultades de Medicina y Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66455, Mexico.
ORCID-Profile: Carolina Rivera-Santiago
Zitieren
APA
Castrillo-Diez, J. L., Rivera-Santiago, C., Ávila-Flores, S. M., Barrera-Barrera, S. A., & Barrera-Saldaña, H. A. (2024). Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico. Viruses. https://doi.org/10.3390/v16060887
Vancouver
Castrillo-Diez JL, Rivera-Santiago C, Ávila-Flores SM, Barrera-Barrera SA, Barrera-Saldaña HA. Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico. Viruses. 2024. doi:10.3390/v16060887
BibTeX
@article{CastrilloDiez2024,
author = {Castrillo-Diez, José L and Rivera-Santiago, Carolina and Ávila-Flores, Silvia M and Barrera-Barrera, Silvia A and Barrera-Saldaña, Hugo A},
title = {Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060887}
}
EUVIMED